SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000927016-01-500076
Filing Date
2001-03-28
Accepted
2001-03-28 00:00:00
Documents
8
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 541004
2 METABOLIC DISORDER COLLABORATION dex1024.txt EX-10.24 190953
3 PHARMACOGENOMICS AGREEMENT dex1025.txt EX-10.25 170142
4 STOCK PURCHASE AGREEMENT dex1026.txt EX-10.26 173956
5 RESTATED COLLABORATION AGREEMENT dex1027.txt EX-10.27 191205
6 SCHEDULE OF COMPUTATION OF NET LOSS PER SHARE dex111.txt EX-11.1 2527
7 SUBSIDIARIES OF THE REGISTRANT dex211.txt EX-21.1 94
8 CONSENT OF DELOITTE & TOUCHE LLP dex231.txt EX-23.1 499
  Complete submission text file 0000927016-01-500076.txt   1272650
Mailing Address
Business Address 555 LONG WHARF DRIVE 11TH FL NEW HAVEN CT 06511 2034013330
CURAGEN CORP (Filer) CIK: 0001030653 (see all company filings)

IRS No.: 061331400 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23223 | Film No.: 1582600
SIC: 8731 Services-Commercial Physical & Biological Research